NAD’s Excedrin Review Gives Novartis A Headache

Novartis will appeal a National Advertising Division recommendation that it discontinue or alter its claim that Extra Strength Excedrin will "start relieving your headache in just 15 minutes.

More from Archive

More from Pink Sheet